Vor Biopharma Inc
NASDAQ:VOR
Income Statement
Earnings Waterfall
Vor Biopharma Inc
Revenue
|
0
USD
|
Operating Expenses
|
-126m
USD
|
Operating Income
|
-126m
USD
|
Other Expenses
|
8.2m
USD
|
Net Income
|
-117.9m
USD
|
Income Statement
Vor Biopharma Inc
Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||
Operating Expenses |
(24)
|
(32)
|
(43)
|
(49)
|
(60)
|
(66)
|
(69)
|
(78)
|
(82)
|
(87)
|
(93)
|
(101)
|
(111)
|
(123)
|
(126)
|
|
Selling, General & Administrative |
(7)
|
(8)
|
(12)
|
(15)
|
(18)
|
(20)
|
(21)
|
(24)
|
(25)
|
(27)
|
(29)
|
(30)
|
(32)
|
(32)
|
(32)
|
|
Research & Development |
(17)
|
(23)
|
(32)
|
(34)
|
(41)
|
(46)
|
(48)
|
(54)
|
(56)
|
(60)
|
(65)
|
(71)
|
(80)
|
(90)
|
(94)
|
|
Operating Income |
(24)
N/A
|
(32)
-34%
|
(43)
-37%
|
(49)
-13%
|
(60)
-21%
|
(66)
-11%
|
(69)
-4%
|
(78)
-13%
|
(82)
-4%
|
(87)
-7%
|
(93)
-7%
|
(101)
-8%
|
(111)
-10%
|
(123)
-10%
|
(126)
-3%
|
|
Pre-Tax Income | ||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
5
|
7
|
8
|
|
Pre-Tax Income |
(23)
N/A
|
(32)
-35%
|
(43)
-37%
|
(49)
-14%
|
(60)
-21%
|
(66)
-11%
|
(69)
-4%
|
(78)
-13%
|
(81)
-4%
|
(86)
-6%
|
(92)
-7%
|
(98)
-6%
|
(106)
-9%
|
(116)
-9%
|
(118)
-2%
|
|
Net Income | ||||||||||||||||
Income from Continuing Operations |
(23)
|
(32)
|
(43)
|
(49)
|
(60)
|
(66)
|
(69)
|
(78)
|
(81)
|
(86)
|
(92)
|
(98)
|
(106)
|
(116)
|
(118)
|
|
Net Income (Common) |
(26)
N/A
|
(36)
-38%
|
(49)
-37%
|
(56)
-13%
|
(65)
-17%
|
(70)
-7%
|
(70)
-1%
|
(78)
-11%
|
(81)
-4%
|
(86)
-6%
|
(92)
-7%
|
(98)
-6%
|
(106)
-9%
|
(116)
-9%
|
(118)
-2%
|
|
EPS (Diluted) |
-0.73
N/A
|
-1
-37%
|
-1.38
-38%
|
-1.51
-9%
|
-1.76
-17%
|
-1.88
-7%
|
-2.1
-12%
|
-2.1
N/A
|
-2.18
-4%
|
-2.27
-4%
|
-2.33
-3%
|
-1.47
+37%
|
-1.58
-7%
|
-1.7
-8%
|
-1.75
-3%
|